118 related articles for article (PubMed ID: 7645257)
1. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region.
Mangold CM; Unckell F; Werr M; Streeck RE
Virology; 1995 Aug; 211(2):535-43. PubMed ID: 7645257
[TBL] [Abstract][Full Text] [Related]
2. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
Abou-Jaoudé G; Sureau C
J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
[TBL] [Abstract][Full Text] [Related]
3. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.
Mangold CM; Streeck RE
J Virol; 1993 Aug; 67(8):4588-97. PubMed ID: 8392600
[TBL] [Abstract][Full Text] [Related]
5. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
6. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
7. Intracellular retention of duck hepatitis B virus large surface protein is independent of preS topology.
Gazina EV; Lin B; Gallina A; Milanesi G; Anderson DA
Virology; 1998 Mar; 242(2):266-78. PubMed ID: 9514970
[TBL] [Abstract][Full Text] [Related]
8. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
Sureau C; Salisse J
Hepatology; 2013 Mar; 57(3):985-94. PubMed ID: 23161433
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
[TBL] [Abstract][Full Text] [Related]
10. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
[TBL] [Abstract][Full Text] [Related]
14. Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.
Bang G; Kim KH; Guarnieri M; Zoulim F; Kawai S; Li J; Wands J; Tong S
Virology; 2005 Feb; 332(1):216-24. PubMed ID: 15661154
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
Weber B
Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
Jeantet D; Chemin I; Mandrand B; Zoulim F; Trepo C; Kay A
Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]